Clearmind Medicine (NASDAQ:CMND) Shares Up 3.5% – Time to Buy?

Clearmind Medicine Inc. (NASDAQ:CMND)’s stock price shot up 3.5% during trading on Thursday . The stock traded as high as $1.36 and last traded at $1.19. 312,450 shares changed hands during mid-day trading, a decline of 75% from the average session volume of 1,238,406 shares. The stock had previously closed at $1.15.

Clearmind Medicine Stock Up 3.5 %

The company has a debt-to-equity ratio of 0.01, a current ratio of 1.71 and a quick ratio of 1.71. The company’s 50 day simple moving average is $1.39 and its 200 day simple moving average is $1.37.

Clearmind Medicine (NASDAQ:CMND) last posted its quarterly earnings data on Monday, September 16th. The company reported ($0.59) EPS for the quarter.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Clearmind Medicine stock. Cornerstone Wealth Group LLC bought a new stake in shares of Clearmind Medicine Inc. (NASDAQ:CMND) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 20,000 shares of the company’s stock, valued at approximately $34,000. Cornerstone Wealth Group LLC owned 1.18% of Clearmind Medicine as of its most recent SEC filing. 96.05% of the stock is currently owned by hedge funds and other institutional investors.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.